Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMJ Case Reports|January 15, 2014
Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresisZoya Georgieva, Matthew PartonBMJ Case Reports|March 15, 2024
Sensory neuropathy as a manifestation of multiple acyl-coenzyme A dehydrogenase deficiencyJessica N Harding, Nika Mohannak, Zoya Georgieva, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2017
Extracellular Lactate: A Novel Measure of T Cell ProliferationJames T Grist, Lorna B Jarvis, Zoya Georgieva, et al.Frontiers in Immunology|August 27, 2021
The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation <i>In Vitro</i>Christopher M Gaunt, Daniel B Rainbow, Ruairi J Mackenzie, et al.Medical Teacher|May 7, 2015
A BEME systematic review of UK undergraduate medical education in the general practice setting: BEME Guide No. 32Sophie Park, Nada F Khan, Mandy Hampshire, et al.Frontiers in Immunology|August 1, 2024
FlowAtlas: an interactive tool for high-dimensional immunophenotyping analysis bridging FlowJo with computational tools in JuliaValerie Coppard, Grisha Szep, Zoya Georgieva, et al.Communications Biology|October 15, 2021
Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73Lorna B Jarvis, Daniel B Rainbow, Valerie Coppard, et al.The Lancet. Neurology|August 21, 2021
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a studyJ William L Brown, Nick G Cunniffe, Ferran Prados, et al.Pageof 1